Back to Search Start Over

Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).

Authors :
Kim, Myeong-Seon
Lee, A. Jin
Shim, Seung-Hyuk
Jang, Eun Bi
Kim, Nam Kyeong
Kim, Min Kyung
Suh, Dong Hoon
Kim, Jeeyeon
Son, Joo-Hyuk
Kong, Tae-Wook
Chang, Suk-Joon
Hwang, Dong Won
Park, Soo Jin
Kim, Hee Seung
Yoo, Ji Geun
Lee, Sung Jong
Lee, Yoo-Young
Source :
Annals of Surgical Oncology: An Oncology Journal for Surgeons; Sep2024, Vol. 31 Issue 9, p6040-6047, 8p
Publication Year :
2024

Abstract

Background: This report describes the oncologic outcomes for patients with advanced ovarian cancer who had bowel surgery performed by gynecologic oncologists (GOs) and compares the outcomes with those for bowel surgery performed by general surgeons (GSs) during maximal cytoreductive surgery. Methods: Patients from six academic institutions who had FIGO stage III or IV ovarian cancer and underwent any bowel surgeries during maximal cytoreductive surgery were eligible for the study. The patients were divided into two groups according to whether bowel surgery was performed by a GO or a GS. In both groups, the GOs were mainly involved in extra bowel debulking procedures. Perioperative and survival outcomes were compared between the two groups. Results: The 761 patients in this study included 113 patients who underwent bowel surgery by a GO and 648 who had bowel surgery by a GS. No discernible differences were observed in age, American Society of Anesthesiology (ASA) score, FIGO stage, histologic type, timing of cytoreductive surgery (primary or interval debulking surgery), or complications between the two groups. The GO group exhibited a shorter operation time than the GS group. Kaplan–Meier analysis showed no survival differences between the two groups. In the Cox analysis, non-serous cell types and gross residual diseases were associated with adverse effects on overall survival. However, performance of bowel surgery by a GO did not have an impact on survival. Conclusion: Performance of bowel surgery by a GO during maximal cytoreductive surgery is both feasible and safe. These results should be reflected in the training system for GOs regarding bowel surgery, and further research is needed to confirm that GOs can play a more leading role in performing extra-uterine procedures. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10689265
Volume :
31
Issue :
9
Database :
Complementary Index
Journal :
Annals of Surgical Oncology: An Oncology Journal for Surgeons
Publication Type :
Academic Journal
Accession number :
178836440
Full Text :
https://doi.org/10.1245/s10434-024-15643-9